Found: 107
Select item for more details and to access through your institution.
A critical appraisal of chronic kidney disease mineral and bone disorders clinical practice guidelines using the AGREE II instrument.
- Published in:
- International Urology & Nephrology, 2017, v. 49, n. 2, p. 273, doi. 10.1007/s11255-016-1436-3
- By:
- Publication type:
- Article
Drug-drug interactions in a cohort of hospitalized elderly patients.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2013, v. 22, n. 10, p. 1054, doi. 10.1002/pds.3510
- By:
- Publication type:
- Article
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 11, p. 914, doi. 10.1002/ajh.22156
- By:
- Publication type:
- Article
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 9, p. 584, doi. 10.1002/ajh.21469
- By:
- Publication type:
- Article
VP57 Test-Retest Reliability Analysis Of The Patient Reported Outcomes Burdens And Experiences (PROBE) Study Questionnaire Test-Retest Reliability Analysis Of The PROBE Study Questionnaire.
- Published in:
- 2017
- By:
- Publication type:
- Abstract
Optimizing a literature surveillance strategy to retrieve sound overall prognosis and risk assessment model papers.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Risk factors for high-titer inhibitor development in children with hemophilia a: results of a cohort study.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Risk Factors for High-Titer Inhibitor Development in Children with Hemophilia A: Results of a Cohort Study.
- Published in:
- BioMed Research International, 2013, v. 2013, p. 1, doi. 10.1155/2013/901975
- By:
- Publication type:
- Article
Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review.
- Published in:
- Systematic Reviews, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s13643-018-0858-7
- By:
- Publication type:
- Article
Effectiveness of Computerized Decision Support Systems Linked to Electronic Health Records: A Systematic Review and Meta-Analysis.
- Published in:
- American Journal of Public Health, 2014, v. 104, n. 12, p. e12, doi. 10.2105/AJPH.2014.302164
- By:
- Publication type:
- Article
A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.
- Published in:
- Blood Transfusion (17232007), 2019, v. 17, n. 5, p. 391, doi. 10.2450/2019.0183-18
- By:
- Publication type:
- Article
Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders.
- Published in:
- European Journal of Haematology, 2022, v. 108, n. 3, p. 232, doi. 10.1111/ejh.13731
- By:
- Publication type:
- Article
McMaster Optimal Aging Portal: an evidence-based database for geriatrics-focused health professionals.
- Published in:
- BMC Research Notes, 2017, v. 10, p. 1, doi. 10.1186/s13104-017-2595-8
- By:
- Publication type:
- Article
Review: Perioperative LMW heparin does not reduce mortality after surgery more than unfractionated heparin in patients with cancer.
- Published in:
- ACP Journal Club, 2008, v. 149, n. 6, p. 9
- By:
- Publication type:
- Article
PP93 HTA Role In CoreHEM, A Multi-Stakeholder Core Outcome Set Project.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Estimated prophylactic dose required to achieve 3% trough as a function of age and concentrate class in multi‐country severe WAPPS‐Hemo haemophilia patients.
- Published in:
- Haemophilia, 2024, v. 30, n. 4, p. 925, doi. 10.1111/hae.15032
- By:
- Publication type:
- Article
Development of a Plasminogen Population PK model supporting prophylactic replacement therapy for Plasminogen deficient patients within the WAPPS‐Hemo platform.
- Published in:
- Haemophilia, 2024, v. 30, n. 4, p. 988, doi. 10.1111/hae.15027
- By:
- Publication type:
- Article
Health utilities in adults with hemophilia A: A retrospective cohort study.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 733, doi. 10.1111/hae.14979
- By:
- Publication type:
- Article
Test–retest reliability of a mobile application of the patient reported outcomes burdens and experiences (PROBE) study.
- Published in:
- Haemophilia, 2024, v. 30, n. 3, p. 702, doi. 10.1111/hae.14969
- By:
- Publication type:
- Article
Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 345, doi. 10.1111/hae.14960
- By:
- Publication type:
- Article
Reported prevalence of von Willebrand disease worldwide in relation to income classification.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 975, doi. 10.1111/hae.14810
- By:
- Publication type:
- Article
Von Willebrand Disease: Gaining a global perspective.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 1104, doi. 10.1111/hae.14804
- By:
- Publication type:
- Article
Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review.
- Published in:
- Haemophilia, 2023, v. 29, n. 4, p. 954, doi. 10.1111/hae.14803
- By:
- Publication type:
- Article
Cost‐utility analysis of emicizumab for the treatment of severe hemophilia A patients in Canada.
- Published in:
- Haemophilia, 2023, v. 29, n. 2, p. 488, doi. 10.1111/hae.14723
- By:
- Publication type:
- Article
Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 33, doi. 10.1111/hae.14676
- By:
- Publication type:
- Article
Switching from standard to extended half‐life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics.
- Published in:
- Haemophilia, 2022, v. 28, n. 6, p. e237, doi. 10.1111/hae.14649
- By:
- Publication type:
- Article
Emicizumab state‐of‐the‐art update.
- Published in:
- Haemophilia, 2022, v. 28, p. 103, doi. 10.1111/hae.14524
- By:
- Publication type:
- Article
Emicizumab state‐of‐the‐art update.
- Published in:
- Haemophilia, 2022, v. 28, p. 103, doi. 10.1111/hae.14524
- By:
- Publication type:
- Article
Sexual issues in people with haemophilia: Awareness and strategies for overcoming communication barriers.
- Published in:
- Haemophilia, 2022, v. 28, n. 1, p. 36, doi. 10.1111/hae.14447
- By:
- Publication type:
- Article
Evaluation of the sexual health in people living with hemophilia.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 993, doi. 10.1111/hae.14410
- By:
- Publication type:
- Article
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half‐life concentrates: A Canadian observational study of real‐world outcomes.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 751, doi. 10.1111/hae.14369
- By:
- Publication type:
- Article
Converting factor and nonfactor usage into a single metric to facilitate benchmarking the resources consumed for haemophilia care across jurisdictions and over time.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. e596, doi. 10.1111/hae.14364
- By:
- Publication type:
- Article
Comparison of single subject and population‐based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. 626, doi. 10.1111/hae.14329
- By:
- Publication type:
- Article
Comparison of quality of life, and emotional and functional profiles in older people with and without severe haemophilia.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e525, doi. 10.1111/hae.14268
- By:
- Publication type:
- Article
Pharmacokinetic implications of dosing emicizumab based on vial size: A simulation study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. 358, doi. 10.1111/hae.14292
- By:
- Publication type:
- Article
Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders.
- Published in:
- Haemophilia, 2021, v. 27, n. 2, p. 211, doi. 10.1111/hae.14247
- By:
- Publication type:
- Article
Non‐severe haemophilia: Is it benign? – Insights from the PROBE study.
- Published in:
- Haemophilia, 2021, v. 27, p. 17, doi. 10.1111/hae.14105
- By:
- Publication type:
- Article
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 966, doi. 10.1111/hae.14144
- By:
- Publication type:
- Article
The World Federation of Hemophilia Annual Global Survey 1999‐2018.
- Published in:
- Haemophilia, 2020, v. 26, n. 4, p. 591, doi. 10.1111/hae.14012
- By:
- Publication type:
- Article
World Federation of Hemophilia Gene Therapy Registry.
- Published in:
- Haemophilia, 2020, v. 26, n. 4, p. 563, doi. 10.1111/hae.14015
- By:
- Publication type:
- Article
Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS‐Hemo project.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. 384, doi. 10.1111/hae.13977
- By:
- Publication type:
- Article
Multicentre pharmacokinetic evaluation of rFVIII‐Fc (efmoroctocog alfa) in a real life and comparison with non‐extended half‐life FVIII concentrates.
- Published in:
- Haemophilia, 2020, v. 26, n. 2, p. 282, doi. 10.1111/hae.13946
- By:
- Publication type:
- Article
Clinical application of Web Accessible Population Pharmacokinetic Service—Hemophilia (WAPPS‐Hemo): Patterns of blood sampling and patient characteristics among clinician users.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 56, doi. 10.1111/hae.13882
- By:
- Publication type:
- Article
Exploring regional variations in the cross‐cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study.
- Published in:
- Haemophilia, 2019, v. 25, n. 3, p. 365, doi. 10.1111/hae.13703
- By:
- Publication type:
- Article
Test‐retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains.
- Published in:
- Haemophilia, 2019, v. 25, n. 1, p. 75, doi. 10.1111/hae.13649
- By:
- Publication type:
- Article
Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age‐matched controls.
- Published in:
- Haemophilia, 2018, v. 24, n. 5, p. 726, doi. 10.1111/hae.13595
- By:
- Publication type:
- Article
Evaluation of the utility of the ISTH- BAT in haemophilia carriers: a multinational study.
- Published in:
- Haemophilia, 2016, v. 22, n. 6, p. 912, doi. 10.1111/hae.13089
- By:
- Publication type:
- Article
Accuracy and Acceptability of Wrist-Wearable Activity-Tracking Devices: Systematic Review of the Literature.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
What You May Have Missed in 2023: Keeping Up With the Constant Flow of New Medical Evidence.
- Published in:
- 2024
- By:
- Publication type:
- Product Review